Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1980 1
1982 1
1986 1
2013 1
2014 2
2018 1
2020 11
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. Boulware DR, et al. Among authors: okafor ec. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3. N Engl J Med. 2020. PMID: 32492293 Free PMC article. Clinical Trial.
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19).
Pastick KA, Okafor EC, Wang F, Lofgren SM, Skipper CP, Nicol MR, Pullen MF, Rajasingham R, McDonald EG, Lee TC, Schwartz IS, Kelly LE, Lother SA, Mitjà O, Letang E, Abassi M, Boulware DR. Pastick KA, et al. Among authors: okafor ec. Open Forum Infect Dis. 2020 Apr 15;7(4):ofaa130. doi: 10.1093/ofid/ofaa130. eCollection 2020 Apr. Open Forum Infect Dis. 2020. PMID: 32363212 Free PMC article. Review.
Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic.
Pullen MF, Pastick KA, Williams DA, Nascene AA, Bangdiwala AS, Okafor EC, Hullsiek KH, Skipper CP, Lofgren SM, Engen N, Abassi M, McDonald EG, Lee TC, Rajasingham R, Boulware DR. Pullen MF, et al. Among authors: okafor ec. Open Forum Infect Dis. 2020 Dec 28;8(2):ofaa602. doi: 10.1093/ofid/ofaa602. eCollection 2021 Feb. Open Forum Infect Dis. 2020. PMID: 33553471 Free PMC article. Review.
Symptoms of COVID-19 Outpatients in the United States.
Pullen MF, Skipper CP, Hullsiek KH, Bangdiwala AS, Pastick KA, Okafor EC, Lofgren SM, Rajasingham R, Engen NW, Galdys A, Williams DA, Abassi M, Boulware DR. Pullen MF, et al. Among authors: okafor ec. Open Forum Infect Dis. 2020 Jun 30;7(7):ofaa271. doi: 10.1093/ofid/ofaa271. eCollection 2020 Jul. Open Forum Infect Dis. 2020. PMID: 33117855 Free PMC article.
Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials.
Lofgren SM, Okafor EC, Colette AA, Pastick KA, Skipper CP, Pullen MF, Nicol MR, Bold TD, Bangdiwala AS, Engen NW, Collins LB, Williams DA, Axelrod ML, Thielen BK, Hullsiek KH, Boulware DR, Rajasingham R. Lofgren SM, et al. Among authors: okafor ec. Open Forum Infect Dis. 2021 Oct 6;8(11):ofab506. doi: 10.1093/ofid/ofab506. eCollection 2021 Nov. Open Forum Infect Dis. 2021. PMID: 35548171 Free PMC article.
The bacterial type III-secreted protein AvrRps4 is a bipartite effector.
Halane MK, Kim SH, Spears BJ, Garner CM, Rogan CJ, Okafor EC, Su J, Bhattacharjee S, Gassmann W. Halane MK, et al. Among authors: okafor ec. PLoS Pathog. 2018 Mar 30;14(3):e1006984. doi: 10.1371/journal.ppat.1006984. eCollection 2018 Mar. PLoS Pathog. 2018. PMID: 29601603 Free PMC article.
Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19.
Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanshi R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Lofgren SM, et al. Among authors: okafor ec. medRxiv [Preprint]. 2020 Sep 21:2020.07.16.20155531. doi: 10.1101/2020.07.16.20155531. medRxiv. 2020. PMID: 32743591 Free PMC article. Updated. Preprint.
Safety of Hydroxychloroquine Among Outpatient Clinical Trial Participants for COVID-19.
Lofgren SM, Nicol MR, Bangdiwala AS, Pastick KA, Okafor EC, Skipper CP, Pullen MF, Engen NW, Abassi M, Williams DA, Nascene AA, Axelrod ML, Lother SA, MacKenzie LJ, Drobot G, Marten N, Cheng MP, Zarychanski R, Schwartz IS, Silverman M, Chagla Z, Kelly LE, McDonald EG, Lee TC, Hullsiek KH, Boulware DR, Rajasingham R. Lofgren SM, et al. Among authors: okafor ec. Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500. doi: 10.1093/ofid/ofaa500. eCollection 2020 Nov. Open Forum Infect Dis. 2020. PMID: 33204764 Free PMC article.
Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial.
Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML, Pullen MF, Nascene AA, Williams DA, Engen NW, Okafor EC, Rini BI, Mayer IA, McDonald EG, Lee TC, Li P, MacKenzie LJ, Balko JM, Dunlop SJ, Hullsiek KH, Boulware DR, Lofgren SM; COVID PREP team. Rajasingham R, et al. Among authors: okafor ec. Clin Infect Dis. 2021 Jun 1;72(11):e835-e843. doi: 10.1093/cid/ciaa1571. Clin Infect Dis. 2021. PMID: 33068425 Free PMC article. Clinical Trial.
20 results